456 filings
Page 2 of 23
S-8
mdtfae
6 Feb 23
Registration of securities for employees
9:31pm
8-K
m7n 7euk3
2 Nov 22
Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:06pm
8-K
swreayx
28 Oct 22
Departure of Directors or Certain Officers
4:16pm
8-K
mectzx9qjq60pqob
13 Oct 22
Departure of Directors or Certain Officers
4:01pm
S-8
vz65i f7cxq7y5
8 Aug 22
Registration of securities for employees
6:58pm
8-K
zoqz7 syg
8 Aug 22
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results
4:11pm
8-K
bk0ks 0fsjorqe
10 Jun 22
Departure of Directors or Certain Officers
4:01pm
S-3ASR
jap1ri
25 May 22
Automatic shelf registration
4:07pm
DEFR14A
j5qrnlwf4s 7nhbg
13 May 22
Revised proxy
5:16pm
8-K
c380xi5
4 May 22
Acadia Pharmaceuticals Reports First Quarter 2022 Financial Results
4:26pm
CT ORDER
9e8tu
4 May 22
Confidential treatment order
12:50pm
8-K
idhvm
8 Apr 22
Departure of Directors or Certain Officers
5:26pm
8-K
a1b 7g8tmzb
28 Feb 22
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:12pm
8-K
ohz06avnm0ricqjkf0bh
20 Dec 21
Acadia Pharmaceuticals Announces Plan for a Resubmission of its
9:26pm
8-K
sj03z2 jbo6fnx
14 Dec 21
Acadia Pharmaceuticals Announces Promotion of Mark Schneyer to Executive Vice
4:52pm